Patrick Van Dreden

R&d
Gennevilliers, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin.

Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin.

Journal: Cancers

Published: March 15, 2026

Effect of PCC on thrombin generation in patients on FXaI with bleeding or needing urgent surgery (GAUGE).

Effect of PCC on thrombin generation in patients on FXaI with bleeding or needing urgent surgery (GAUGE).

Journal: Blood advances

Published: February 23, 2026

Lipoprotein(a) plasma levels and coagulation biomarkers: Results from a comprehensive laboratory assessment in an angiographically controlled cardiovascular cohort.

Lipoprotein(a) plasma levels and coagulation biomarkers: Results from a comprehensive laboratory assessment in an angiographically controlled cardiovascular cohort.

Journal: Journal of clinical lipidology

Published: December 29, 2025

Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease.

Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease.

Journal: Thrombosis research

Published: April 28, 2025

Influence of Direct Oral Anticoagulant Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case-Control Study.

Influence of Direct Oral Anticoagulant Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case-Control Study.

Journal: Thrombosis and haemostasis

Published: January 21, 2025

Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence.

Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence.

Journal: International angiology : a journal of the International Union of Angiology

Published: February 29, 2024

The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents.

The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents.

Journal: Thrombosis research

Published: January 16, 2024

Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival.

Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival.

Journal: Research and practice in thrombosis and haemostasis

Published: July 17, 2023

Tissue factor pathway-related biomarkers in liver cancer: activated factor VII-antithrombin complex and tissue factor mRNA levels are associated with mortality.

Tissue factor pathway-related biomarkers in liver cancer: activated factor VII-antithrombin complex and tissue factor mRNA levels are associated with mortality.

Journal: Research and practice in thrombosis and haemostasis

Published: April 29, 2023

PARP Inhibitor Inhibits the Vasculogenic Mimicry through a NF-κB-PTX3 Axis Signaling in Breast Cancer Cells.

PARP Inhibitor Inhibits the Vasculogenic Mimicry through a NF-κB-PTX3 Axis Signaling in Breast Cancer Cells.

Journal: International journal of molecular sciences

Published: October 12, 2022

High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis.

High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis.

Journal: Diagnostics (Basel, Switzerland)

Published: September 09, 2022

Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease.

Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease.

Journal: BMC gastroenterology

Published: August 30, 2022

Showing 1-12 of 49

Last Updated: 09/26/2026